Sex Steroid Hormones and Gut Microbiome

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Journal of Clinical Sexology - Vol. 2, No. 2: April-June 2019 73 Original article SEX STEROID HORMONES AND GUT MICROBIOME *Assoc. Prof. Dr. Manole Cojocaru Titu Maiorescu University of Bucharest, Faculty of Medicine Abstract: Commensal bacteria and their genes associated with host are known as microbiome. Bac- terial influence on endocrine system is difficult to understand and investigate, however new metabolomics and bioinformatics research provide information about bidirectional cross talk between host hormones and microbiome. The gut microbiota in particular plays impor- tant roles in host metabolism, immunity and even behavior. Bacteria are capable of metabo- lizing sex steroid hormones through the activity of distinct enzymes such as hydroxysteroid dehydrogenase that regulate the balance between active and inactive steroids. However, only recently has a critical mechanism of bacterial interaction been revealed: modulation of hor- monal secretion. Surprisingly, commensal bacteria can produce and secrete hormones. The gut microbiome has been shown to be influenced by estrogen, however, the gut microbiome also significantly impacts estrogen levels. This review summarizes current knowledge of the complex interplay between sex steroid hormone, and the gut microbiome. Keywords: gut microbiota, sex differences, sex steroid hormone, testosterone, estradiol *Correspondence: Assoc. Prof. Dr. Manole Cojocaru, Bucharest, Romania; e-mail : [email protected] 74 Journal of Clinical Sexology - Vol. 2, No. 2: April-June 2019 The human gut microbiome is a complex how the gut microbiota can influence hormo- microbial ecosystem that plays an important ne levels. Sex differences in the gut microbi- role in our health. The age and sex of an in- ota have been reported in humans as well (5). dividual strongly influences the bacterial Microbial composition or activity of the diversity of the gut microbiome. Based on gut can be modified by a variety of factors, available evidence, it is, however, pertinent including internal factors such as hormonal to ask if sex steroids participate in the re- changes, or external factors such as diet, an- gulation of the composition or function of tibiotics and stress (6,7). gut microbiota, or if gut microbes regulate sex steroid balance. While gonadal stero- Steroid hormones can affect the gut mi- ids can alter the gut microbiota, it appears crobiota. Sex differences have been noted in that, in turn, the gut microbiome can influ- the composition of the gut microbiota. For ence hormone levels. Gut microbiota plays example, men have higher levels of Bacte- roles in host physiology including endocrine roidetes and Prevotella than women (8-10). function. Greater microbial diversity in the The gut microbiome can influence hormo- female gut may be associated with sex hor- ne levels. Other studies suggest that steroids mones. That is why in recent years the con- influence the gut microbial communities. For ception of humanmicrobiome superorganism example, the gut microbiota undergoes pro- was proposed (1). Although the field of mi- found changes during pregnancy in women. crobiome research is new and developing, Koren et al found a large shift in the gut mi- a significant number of studies already link crobiota from the first to third trimester, with hormones and the gut microbiota. Pathoge- an increase in overall diversity and a prolife- nic bacteria also have an influence over host ration of Proteobacteria and Actinobacteria, sex hormone metabolism. Dysbiosis of the resulting in changes in metabolism (11,12). gut microbiota may also play a role in the In postmenopausal women, gut microbi- development of diseases manifested by hor- ota diversity was positively associated with monal imbalance, such as polycystic ovary the ratio of oestrogen metabolites in urine syndrome, through their modulation of hor- (13,14). mone levels (2,3). These studies highlight the reciprocal According to this theory, poor diet leads connections between sex hormones and gut to changes in gut bacterial communities, microbiota. Taken together, these studies pro- creating an increase in gut mucosal perme- vide strong evidence that the gut microbiota ability, resulting in activation of the immune is influenced by gonadal steroid hormones system. This, in turn, raises serum insulin and steroid levels can be altered by the gut levels, increases androgen production in the microbiome (15) ovaries and interferes with normal follicle development (4). Diet has profound effects on the structure The gut microbiome has a profound im- and activity of gut microorganisms (16,17). pact on human health and disease. Steroids For example, a diet rich in fats promotes can influence the gut microbiota and, in turn, the growth of the proinflammatory Gram-ne- Journal of Clinical Sexology - Vol. 2, No. 2: April-June 2019 75 gative microorganisms, which in turn can al- as they are both derivatives of cholesterol ter immune homeostasis (18) which contains cyclic steroid nucleus. They can both be recycled through enterohepatic Understanding the role of the gut micro- circulation-a process, in part, regulated by biome in human health presents a number of the gut microbiome. Therefore, the action of challenges. Human gut microbiota contribu- gut microbes on these steroids is critical in tes to changes in composition of circulating determining whether they are excreted or re- hormones and, on the other hand, hormones cycled. Various microbial modifications also can influence gut microbiome (19). alter the cytotoxicity and/or potency of the- The gut microbiome is critical for ma- se steroids. The term “sterolbiome” has been intaining a normal estrous cycle, testost- recently proposed to describe the genetic erone levels, and reproductive function. potential of the gut microbiome to produce Gut microbes modulate the enterohepatic endocrine molecules from endogenous and recirculation of estrogens and androgens, exogenous steroids. Furthermore, the gut mi- affecting local and systemic levels of sex ste- crobiome also modulates glucocorticoids and roid hormones. Gut bacteria can also gene- androgens through reductive and oxidative rate androgens from glucocorticoids. Similar reactions. The ability of gut microbes to to bile acids, endogenous sex steroid hormo- convert steroids anaerobically through side- nes such as androgens, estrogens, and pro- chain cleavage has been known for decades, gestogens, are derived from cholesterol. but the pathways involved have only been Gut microbial metabolism affects systemic recently identified. The gut microbiome is hi- levels, potency, and the half-life of estrogen ghly sensitive to environmental perturbation; metabolites (20). therefore, variations in diet, hormonal status, exercise (duration and intensity), and stress Humans harbor over 100 trillion micro- levels should be considered when designing bes, with the gastrointestinal tract being the microbiome studies in humans. Further, it has most densely populated body habitat. Gut mi- been shown that gut microbiota differences crobial communities include members of the are mediated by sex hormones and the influ- Bacteria, Archaea, and Eukarya (fungi, pro- ences of gonadectomy on bile acid profiles tozoa) domains, as well as viruses. Sex ste- significantly differ between sexes (24). roid hormones also modulate gastrointestinal health (21,22). In addition to bacterial pathogens, bacte- ria from human microbiota play an important In females, GI permeability fluctuates role in the metabolism of sex hormones. The throughout the estrous cycle, and ovariec- estrobolome is defined as the gene reperto- tomy-induced estrogen deficiency leads to ire of the microbiota of the gut that are ca- compromised barrier function (23). pable of metabolizing estrogens. Dysbiosis This evidence supports that, besides the and a reduction of gut microbiota diversity role in reproductive functions, sex steroid impacts the estrobolome. A reduction in gut hormones play important roles in gastro- microbiota diversity leads to a decrease in the intestinal homeostasis. Sex steroid hormo- estrogen metabolism through a lack of estro- nes and bile acids share structural similarity gen metabolizing bacteria. A lack of estrogen 76 Journal of Clinical Sexology - Vol. 2, No. 2: April-June 2019 metabolizing bacteria leads to a decrease in with direct evidence of testosterone synthesis circulating estrogens which may influence from bacteria that inhabit the gut alludes to hypoestrogen-related disease ( 25,26). Fig. 1, the existence of the “testobolome” (26) Fig 2 Gut epithelial barrier integrity can also be Testosterone has been shown to be pro- modified by estrogen (27). duced in the gut by Clostridium scindens. Remarkably, administration of antibiotics Evidence of an increase in testosterone le- leads to a 60-fold increase in the fecal excre- vels due to gut microbiome transfer coupled tion of conjugated estrogens in pregnant wo- Fig. 1 Estrogen-gut microbiome interactions exhibit physiological and clinical implications (25) Journal of Clinical Sexology - Vol. 2, No. 2: April-June 2019 77 Fig. 2 The estrobolome and enterohepatic circulation of estrogens (26). men, highlighting the central role of the gut bes remained unexplored. The current study microbiome in modulating the reabsorption investigates the relationship between gut of estrogens (28,29). microbes and serum levels of testosterone in men and estradiol in women. These results Several studies have assessed compositio- demonstrate that sex steroid hormone
Recommended publications
  • Detectx® Serum 17Β-Estradiol Enzyme Immunoassay Kit

    Detectx® Serum 17Β-Estradiol Enzyme Immunoassay Kit

    DetectX® Serum 17β-Estradiol Enzyme Immunoassay Kit 1 Plate Kit Catalog Number KB30-H1 5 Plate Kit Catalog Number KB30-H5 Species Independent Sample Types Validated: Multi-Species Serum and Plasma Please read this insert completely prior to using the product. For research use only. Not for use in diagnostic procedures. www.ArborAssays.com KB30-H WEB 210308 TABLE OF CONTENTS Background 3 Assay Principle 4 Related Products 4 Supplied Components 5 Storage Instructions 5 Other Materials Required 6 Precautions 6 Sample Types 7 Sample Preparation 7 Reagent Preparation 8 Assay Protocol 9 Calculation of Results 10 Typical Data 10-11 Validation Data Sensitivity, Linearity, etc. 11-13 Samples Values and Cross Reactivity 14 Warranty & Contact Information 15 Plate Layout Sheet 16 ® 2 EXPECT ASSAY ARTISTRY KB30-H WEB 210308 BACKGROUND 17β-Estradiol, C18H24O2, also known as E2 or oestradiol (1, 3, 5(10)-Estratrien-3, 17β-diol) is a key regulator of growth, differentiation, and function in a wide array of tissues, including the male and female reproductive tracts, mammary gland, brain, skeletal and cardiovascular systems. The predominant biological effects of E2 are mediated through two distinct intracellular receptors, ERα and ERβ, each encoded by unique genes possessing the functional domain characteristics of the steroid/thyroid hormone superfamily of nuclear receptors1. ERα is the predominant form expressed in the breast, uterus, cervix, and vagina. ERβ exhibits a more limited pattern and is primarily expressed in the ovary, prostate, testis, spleen, lung, hypothalamus, and thymus2. Estradiol also influences bone growth, brain development and maturation, and food intake3, and it is also critical in maintaining organ functions during severe trauma4,5.
  • A Guide to Feminizing Hormones – Estrogen

    A Guide to Feminizing Hormones – Estrogen

    1 | Feminizing Hormones ​ ​ A Guide to Feminizing Hormones Hormone therapy is an option that can help transgender and gender-diverse people feel more comfortable in their bodies. Like other medical treatments, there are benefits and risks. Knowing what to expect will help us work together to maximize the benefits and minimize the risks. What are hormones? Hormones are chemical messengers that tell the body’s cells how to function, ​ when to grow, when to divide, and when to die. They regulate many functions, including growth, sex drive, hunger, thirst, digestion, metabolism, fat burning & storage, blood sugar, cholesterol levels, and reproduction. What are sex hormones? Sex hormones regulate the development of sex characteristics, including the sex ​ organs such as genitals and ovaries/testicles. Sex hormones also affect the secondary sex characteristics that typically develop at puberty, like facial and body hair, bone growth, breast growth, and voice changes. There are three categories of sex hormones in the body: • Androgens: testosterone, dehydroepiandrosterone (DHEA), ​ dihydrotestosterone (DHT) • Estrogens: estradiol, estriol, estrone ​ • Progestin: progesterone ​ Generally, “males” tend to have higher androgen levels, and “females” tend to have higher levels of estrogens and progestogens. What is hormone therapy? Hormone therapy is taking medicine to change the levels of sex hormones in your body. Changing these levels will affect your hair growth, voice pitch, fat distribution, muscle mass, and other features associated with sex and gender. Feminizing hormone therapy can help make the body look and feel less “masculine” and more “feminine" — making your body more closely match your identity. What medicines are involved? There are different kinds of medicines used to change the levels of sex hormones in your body.
  • Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals

    Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals

    Journal of Clinical Medicine Review Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals Carlotta Cocchetti 1, Jiska Ristori 1, Alessia Romani 1, Mario Maggi 2 and Alessandra Daphne Fisher 1,* 1 Andrology, Women’s Endocrinology and Gender Incongruence Unit, Florence University Hospital, 50139 Florence, Italy; [email protected] (C.C); jiska.ristori@unifi.it (J.R.); [email protected] (A.R.) 2 Department of Experimental, Clinical and Biomedical Sciences, Careggi University Hospital, 50139 Florence, Italy; [email protected]fi.it * Correspondence: fi[email protected] Received: 16 April 2020; Accepted: 18 May 2020; Published: 26 May 2020 Abstract: Introduction: To date no standardized hormonal treatment protocols for non-binary transgender individuals have been described in the literature and there is a lack of data regarding their efficacy and safety. Objectives: To suggest possible treatment strategies for non-binary transgender individuals with non-standardized requests and to emphasize the importance of a personalized clinical approach. Methods: A narrative review of pertinent literature on gender-affirming hormonal treatment in transgender persons was performed using PubMed. Results: New hormonal treatment regimens outside those reported in current guidelines should be considered for non-binary transgender individuals, in order to improve psychological well-being and quality of life. In the present review we suggested the use of hormonal and non-hormonal compounds, which—based on their mechanism of action—could be used in these cases depending on clients’ requests. Conclusion: Requests for an individualized hormonal treatment in non-binary transgender individuals represent a future challenge for professionals managing transgender health care. For each case, clinicians should balance the benefits and risks of a personalized non-standardized treatment, actively involving the person in decisions regarding hormonal treatment.
  • Gender-Affirming Hormone Therapy

    Gender-Affirming Hormone Therapy

    GENDER-AFFIRMING HORMONE THERAPY Julie Thompson, PA-C Medical Director of Trans Health, Fenway Health March 2020 fenwayhealth.org GOALS AND OBJECTIVES 1. Review process of initiating hormone therapy through the informed consent model 2. Provide an overview of masculinizing and feminizing hormone therapy 3. Review realistic expectations and benefits of hormone therapy vs their associated risks 4. Discuss recommendations for monitoring fenwayhealth.org PROTOCOLS AND STANDARDS OF CARE fenwayhealth.org WPATH STANDARDS OF CARE, 2011 The criteria for hormone therapy are as follows: 1. Well-documented, persistent (at least 6mo) gender dysphoria 2. Capacity to make a fully informed decision and to consent for treatment 3. Age of majority in a given country 4. If significant medical or mental health concerns are present, they must be reasonably well controlled fenwayhealth.org INFORMED CONSENT MODEL ▪ Requires healthcare provider to ▪ Effectively communicate benefits, risks and alternatives of treatment to patient ▪ Assess that the patient is able to understand and consent to the treatment ▪ Informed consent model does not preclude mental health care! ▪ Recognizes that prescribing decision ultimately rests with clinical judgment of provider working together with the patient ▪ Recognizes patient autonomy and empowers self-agency ▪ Decreases barriers to medically necessary care fenwayhealth.org INITIAL VISITS ▪ Review history of gender experience and patient’s goals ▪ Document prior hormone use ▪ Assess appropriateness for gender affirming medical
  • Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs That Modulate Farnesoid X Receptor

    Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs That Modulate Farnesoid X Receptor

    OPEN Quantitative High-Throughput Profiling of SUBJECT AREAS: Environmental Chemicals and Drugs that SCREENING SMALL MOLECULES Modulate Farnesoid X Receptor Chia-Wen Hsu1, Jinghua Zhao1, Ruili Huang1, Jui-Hua Hsieh2, Jon Hamm3, Xiaoqing Chang3, Keith Houck4 Received & Menghang Xia1 27 June 2014 Accepted 1National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, 2Division of the National 29 August 2014 Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 3Integrated Laboratory Systems, Inc., Morrisville, NC, 4U.S. Environmental Protection Agency, Research Triangle Park, NC. Published 26 September 2014 The farnesoid X receptor (FXR) regulates the homeostasis of bile acids, lipids, and glucose. Because endogenous chemicals bind and activate FXR, it is important to examine which xenobiotic compounds Correspondence and would disrupt normal receptor function. We used a cell-based human FXR b-lactamase (Bla) reporter gene assay to profile the Tox21 10K compound collection of environmental chemicals and drugs. requests for materials Structure-activity relationships of FXR-active compounds revealed by this screening were then compared should be addressed to against the androgen receptor, estrogen receptor a, peroxisome proliferator-activated receptors d and c, and M.X. ([email protected]. the vitamin D receptor. We identified several FXR-active structural classes including anthracyclines, gov) benzimidazoles, dihydropyridines, pyrethroids, retinoic acids, and vinca alkaloids. Microtubule inhibitors potently decreased FXR reporter gene activity. Pyrethroids specifically antagonized FXR transactivation. Anthracyclines affected reporter activity in all tested assays, suggesting non-specific activity. These results provide important information to prioritize chemicals for further investigation, and suggest possible modes of action of compounds in FXR signaling.
  • Neurosteroid Metabolism in the Human Brain

    Neurosteroid Metabolism in the Human Brain

    European Journal of Endocrinology (2001) 145 669±679 ISSN 0804-4643 REVIEW Neurosteroid metabolism in the human brain Birgit Stoffel-Wagner Department of Clinical Biochemistry, University of Bonn, 53127 Bonn, Germany (Correspondence should be addressed to Birgit Stoffel-Wagner, Institut fuÈr Klinische Biochemie, Universitaet Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany; Email: [email protected]) Abstract This review summarizes the current knowledge of the biosynthesis of neurosteroids in the human brain, the enzymes mediating these reactions, their localization and the putative effects of neurosteroids. Molecular biological and biochemical studies have now ®rmly established the presence of the steroidogenic enzymes cytochrome P450 cholesterol side-chain cleavage (P450SCC), aromatase, 5a-reductase, 3a-hydroxysteroid dehydrogenase and 17b-hydroxysteroid dehydrogenase in human brain. The functions attributed to speci®c neurosteroids include modulation of g-aminobutyric acid A (GABAA), N-methyl-d-aspartate (NMDA), nicotinic, muscarinic, serotonin (5-HT3), kainate, glycine and sigma receptors, neuroprotection and induction of neurite outgrowth, dendritic spines and synaptogenesis. The ®rst clinical investigations in humans produced evidence for an involvement of neuroactive steroids in conditions such as fatigue during pregnancy, premenstrual syndrome, post partum depression, catamenial epilepsy, depressive disorders and dementia disorders. Better knowledge of the biochemical pathways of neurosteroidogenesis and
  • Convergence of Multiple Mechanisms of Steroid Hormone Action

    Convergence of Multiple Mechanisms of Steroid Hormone Action

    Review 569 Convergence of Multiple Mechanisms of Steroid Hormone Action Authors S. K. Mani 1 * , P. G. Mermelstein 2 * , M. J. Tetel 3 * , G. Anesetti 4 * Affi liations 1 Department of Molecular & Cellular Biology and Neuroscience, Baylor College of Medicine, Houston, TX, USA 2 Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA 3 Neuroscience Program, Wellesley College, Wellesley, MA, USA 4 Departamento de Hostologia y Embriologia, Facultad de Medicine, Universidad de la Republica, Montevideo, Uruguay Key words Abstract receptors can also be activated in a “ligand-inde- ● ▶ estrogen ▼ pendent” manner by other factors including neu- ● ▶ progesterone Steroid hormones modulate a wide array of rotransmitters. Recent studies indicate that rapid, ▶ ● signaling physiological processes including development, nonclassical steroid eff ects involve extranuclear ● ▶ cross-talk metabolism, and reproduction in various species. steroid receptors located at the membrane, which ● ▶ ovary ● ▶ brain It is generally believed that these biological eff ects interact with cytoplasmic kinase signaling mol- are predominantly mediated by their binding to ecules and G-proteins. The current review deals specifi c intracellular receptors resulting in con- with various mechanisms that function together formational change, dimerization, and recruit- in an integrated manner to promote hormone- ment of coregulators for transcription-dependent dependent actions on the central and sympathetic genomic actions (classical mechanism). In addi- nervous systems. tion, to their cognate ligands, intracellular steroid Abbreviations gene expression and function. Interestingly, not ▼ all the “classical” receptors are intranuclear and CBP CREB binding protein can be associated at the membrane. As described CRE CREB response element in this review, extranuclear ERs and PRs at the DAR Dopamine receptor (DAR) membrane or in the cytoplasm can interact with ER Estrogen receptor G proteins and signaling kinases, and other G received 13 .
  • Pharmacology/Therapeutics II Block III Lectures 2013-14

    Pharmacology/Therapeutics II Block III Lectures 2013-14

    Pharmacology/Therapeutics II Block III Lectures 2013‐14 66. Hypothalamic/pituitary Hormones ‐ Rana 67. Estrogens and Progesterone I ‐ Rana 68. Estrogens and Progesterone II ‐ Rana 69. Androgens ‐ Rana 70. Thyroid/Anti‐Thyroid Drugs – Patel 71. Calcium Metabolism – Patel 72. Adrenocorticosterioids and Antagonists – Clipstone 73. Diabetes Drugs I – Clipstone 74. Diabetes Drugs II ‐ Clipstone Pharmacology & Therapeutics Neuroendocrine Pharmacology: Hypothalamic and Pituitary Hormones, March 20, 2014 Lecture Ajay Rana, Ph.D. Neuroendocrine Pharmacology: Hypothalamic and Pituitary Hormones Date: Thursday, March 20, 2014-8:30 AM Reading Assignment: Katzung, Chapter 37 Key Concepts and Learning Objectives To review the physiology of neuroendocrine regulation To discuss the use neuroendocrine agents for the treatment of representative neuroendocrine disorders: growth hormone deficiency/excess, infertility, hyperprolactinemia Drugs discussed Growth Hormone Deficiency: . Recombinant hGH . Synthetic GHRH, Recombinant IGF-1 Growth Hormone Excess: . Somatostatin analogue . GH receptor antagonist . Dopamine receptor agonist Infertility and other endocrine related disorders: . Human menopausal and recombinant gonadotropins . GnRH agonists as activators . GnRH agonists as inhibitors . GnRH receptor antagonists Hyperprolactinemia: . Dopamine receptor agonists 1 Pharmacology & Therapeutics Neuroendocrine Pharmacology: Hypothalamic and Pituitary Hormones, March 20, 2014 Lecture Ajay Rana, Ph.D. 1. Overview of Neuroendocrine Systems The neuroendocrine
  • PRIMOLUT N (NORETHISTERONE) How Does It Work? Contraindications

    PRIMOLUT N (NORETHISTERONE) How Does It Work? Contraindications

    PRIMOLUT N (NORETHISTERONE) How Does it Work? Primolut N tables contain the active ingredient norethisterone, which is a synthetic hormone similar to the naturally occurring sex hormone, progesterone. It is used in a wide range of menstrual disorders. (NB: Norethisterone is also available without a brand name, ie as the generic medicine). In women, progesterone is responsible for the development of a healthy womb lining (endometrium) that is necessary for pregnancy. The body produces progesterone at certain times of the menstrual cycle, causing the womb lining to flourish. If a fertilised egg does not attach to the womb lining by the end of the monthly cycle, progesterone levels in the body decrease. This causes the body to shed the womb lining (a menstrual period). If a fertilised egg successfully attaches to the womb lining by the end of the monthly cycle, progesterone levels in the body remain high. This helps maintain a healthy womb lining for the ongoing pregnancy. Norethisterone mimics the effects of your natural progesterone and so can help regulate the healthy growth and normal shedding of the womb lining. It may be used in the treatment of menstrual disorders such as irregular or painful menstrual periods, premenstrual syndrome and endometriosis. It may also be used to delay the onset of menstruation for special circumstances, such as if travelling or taking part in a sporting event. Norethisterone is usually taken on selected days during the menstrual cycle, depending on the disorder that is being treated. You will be advised by Dr. Rasmuson when to commence and cease this medication.
  • Dehydroepiandrosterone an Inexpensive Steroid Hormone That Decreases the Mortality Due to Sepsis Following Trauma-Induced Hemorrhage

    Dehydroepiandrosterone an Inexpensive Steroid Hormone That Decreases the Mortality Due to Sepsis Following Trauma-Induced Hemorrhage

    PAPER Dehydroepiandrosterone An Inexpensive Steroid Hormone That Decreases the Mortality Due to Sepsis Following Trauma-Induced Hemorrhage Martin K. Angele, MD; Robert A. Catania, MD; Alfred Ayala, PhD; William G. Cioffi, MD; Kirby I. Bland, MD; Irshad H. Chaudry, PhD Background: Recent studies suggest that male sex ste- hemorrhage and resuscitation, the animals were killed roids play a role in producing immunodepression follow- and blood, spleens, and peritoneal macrophages were har- ing trauma-hemorrhage. This notion is supported by stud- vested. Splenocyte proliferation and interleukin (IL) 2 ies showing that castration of male mice before trauma- release and splenic and peritoneal macrophage IL-1 and hemorrhage or the administration of the androgen receptor IL-6 release were determined. In a separate set of experi- blocker flutamide following trauma-hemorrhage in non- ments, sepsis was induced by cecal ligation and punc- castrated animals prevents immunodepression and im- ture at 48 hours after trauma-hemorrhage and resusci- proves the survival rate of animals subjected to subse- tation. For those studies, the animals received vehicle, a quent sepsis. However, it remains unknown whether the single 100-µg dose of DHEA, or 100 µg/d DHEA for 3 most abundant steroid hormone, dehydroepiandros- days following hemorrhage and resuscitation. Survival terone (DHEA), protects or depresses immune functions was monitored for 10 days after the induction of sepsis. following trauma-hemorrhage. In this regard, DHEA has been reported to have estrogenic and androgenic proper- Results: Administration of DHEA restored the de- ties, depending on the hormonal milieu. pressed splenocyte and macrophage functions at 24 hours after trauma-hemorrhage.
  • Low Testosterone (Hypogonadism)

    Low Testosterone (Hypogonadism)

    Low Testosterone (Hypogonadism) Testosterone is an anabolic-androgenic steroid hormone which is made in the testes in males (a minimal amount is also made in the adrenal glands). Testosterone has two major functions in the human body. Testosterone production is regulated by hormones released from the brain. The brain and testes work together to keep testosterone in the normal range (between 199 ng/dL and 1586 ng/dL) Testosterone is needed to form and maintain the male sex organs, regulate sex drive (libido) and promote secondary male sex characteristics such as voice deepening and development of facial and body hair. Testosterone facilitates muscle growth as well as bone development and maintenance. Low testosterone levels in the blood are seen in males with a medical condition known as Hypogonadism. This may be due to a signaling problem between the brain and testes that can cause production to slow or stop. Hypogonadism can also be caused by a problem with production in the testes themselves. Causes Primary: This type of hypogonadism — also known as primary testicular failure — originates from a problem in the testicles. Secondary: This type of hypogonadism indicates a problem in the hypothalamus or the pituitary gland — parts of the brain that signal the testicles to produce testosterone. The hypothalamus produces gonadotropin- releasing hormone, which signals the pituitary gland to make follicle-stimulating hormone (FSH) and luteinizing hormone. Luteinizing hormone then signals the testes to produce testosterone. Either type of hypogonadism may be caused by an inherited (congenital) trait or something that happens later in life (acquired), such as an injury or an infection.
  • Effect of Spironolactone and Potassium Canrenoate on Cytosolic and Nuclear Androgen and Estrogen Receptors of Rat Liver

    Effect of Spironolactone and Potassium Canrenoate on Cytosolic and Nuclear Androgen and Estrogen Receptors of Rat Liver

    GASTROENTEROLOGY 1987;93:681-6 Effect of Spironolactone and Potassium Canrenoate on Cytosolic and Nuclear Androgen and Estrogen Receptors of Rat Liver ANTONIO FRANCAVILLA, ALFREDO DJ LEO, PATRICIA K. EAGON, LORENZO POLIMENO, FRANCESCO GUGLIELMI, GIUSEPPE F ANIZZA, MICHELE BARONE, and THOMAS E. STARZL Departments of Gastroenterology and Obstetrics and Gynecology, University of Bari, Bari, Italy; Departments of Medicine and Surgery, University of Pittsburgh, School of Medicine, and Veterans Administration Medical Center, Pittsburgh, Pennsylvania Spironolactone and potassium canrenoate are di­ spironolactone. This reduction in hepatic AR con­ uretics that are used widely for management of tent suggested loss of androgen responsiveness of cirrhotic ascites. The administration of spironolac­ liver. We confirmed this by assessing levels of MEB , tone frequently leads to feminization, which has and found that livers from group 2 animals had no been noted less frequently with the use of potassium detectable MEB activity, whereas livers from both canrenoate, a salt of the active metabolite of spi­ group 1 and 3 had normal MEB activity. No changes ronolactone. The use of these two drugs has been were observed in nuclear ER and cytosolic ER of associated with decreases in serum testosterone lev­ group 3 as compared with group 1. Nuclear estrogen els and spironolactone with a reduction in androgen receptor decreased and cytosolic ER increased in receptor (AR) activity. This decrease in AR has been group 2, but with no change in total ER content. cited as the cause of the anti androgen effect of these These results indicate that (a) only spironolactone drugs. We therefore assessed the effect of both drugs appears to act as an antiandrogen in liver, resulting on levels of androgen and estrogen receptors (ER) in in a decrease in both AR and male specific estrogen the liver, a tissue that is responsive to sex steroids.